Pain Management
Q&A: Medical marijuana can alleviate pain, anxiety associated with skin disease
Patients are growing increasingly interested in medical marijuana. As this interest grows, dermatologists must be prepared to navigate the ethical, legal and scientific complexities of its use, according to an expert.
Patients want to talk about cannabis, but get most information from dispensary workers
NEW ORLEANS — Evidence suggests that, for many patients, the harms of cannabis outweigh its potential benefits for chronic noncancer pain, according to new Best Practice Advice from ACP.
Transnasal cooling device shows promise for migraine pain
SAN DIEGO — Significantly more patients with acute migraine who received a 10 L per minute dose of a transnasal cooling device had pain freedom at 2 hours vs. those who received sham, according to research presented at the AAN Annual Meeting.
Q&A: Recognizing and adequately treating pain during gynecologic procedures
Pelvic exams and procedures are a routine part of ambulatory gynecology, yet research suggests some women experience pain that goes unrecognized or undertreated, eroding trust and putting patients at risk for having pain poorly managed.
Q&A: Spinal cord stimulation system offers nonopioid solution to pain management
The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.
More teaching needed to help stop ‘erosion of empathy’ in medical students
In response to the insightful cover story, “‘A potent medicine’: In matters of pain and trust, empathy may make all the difference,” published in the Healio Rheumatology January 2025 issue, I would like to highlight the key data on empathy.
Remifentanil, sufentanil may be linked with poor pain outcomes after elective surgery
Published results showed intraoperative use of remifentanil and sufentanil was independently associated with poor postoperative pain outcomes for patients undergoing elective surgery with general anesthesia.
40% of people treated with chemotherapy develop persistent, severe nerve pain
Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.
Q&A: Pain management possible for patients with drug allergies
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.
FDA approves nonopioid Journavx for moderate to severe acute pain
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.